相关实验视频
Updated: Jul 17, 2025

09:51
Laparoscopic Anterior Right Hepatectomy: A Single-Center Experience
Published on: December 4, 2023
1.1K
HLA-B27,轴性脊椎关节炎和生存率
Zhixiu Li1,2, Mohammad Kazim Khan3, Sjef M van der Linden4,5
1School of Public Health and Emergency Management, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Annals of the rheumatic diseases
|September 7, 2023
概括
化脊柱炎 (AS) 患者的预期寿命缩短,尤其是携带HLA-B27基因的女性. 然而,在一般人群中,HLA-B27基因携带不会影响存活率或血管疾病死亡率.
科学领域:
- 类风湿病学 类风湿病学
- 遗传学 是一个遗传学.
- 流行病学 流行病学
背景情况:
- 结节性脊柱炎 (AS) 和HLA-B27基因携带与增加的死亡率有事相关.
- 之前的研究尚未确定AS和HLA-B27对长期生存的影响.
研究的目的:
- 评估AS和HLA-B27基因携带与死亡率增加有关的假设.
- 根据HLA-B27状态分析AS患者和一般人群的生存率.
主要方法:
- 来自瑞士AS患者协会的377名AS患者的35年随访研究,分析了预期寿命和HLA-B27状态.
- 在英国生物库中对407,480名欧洲祖先参与者的生存分析,检查HLA-B27携带和死亡率之间的关联.
主要成果:
- 与一般人群相比,AS患者的标准化死亡率 (SMR) 显著增加 (SMR 1.37).
- 在HLA-B27阳性AS患者中,特别是女性 (SMR 1.77) 中,特别注意到死亡率的增加.
- 在英国一般生物库人口中,HLA-B27携带与死亡率或血管疾病风险的显著变化无关.
结论:
- 与非放射性 axSpA 患者不同,AS 患者的预期寿命显著缩短.
- 当HLA-B27基因本身存在于没有AS的普通人群中时,似乎不会影响存活率或增加血管疾病死亡风险.
相关概念视频
Cancer Survival Analysis
381
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
381
Assumptions of Survival Analysis
153
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
153
Actuarial Approach
96
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
96
Comparing the Survival Analysis of Two or More Groups
220
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
220

